首页|消癌平注射液对多西紫杉醇在大鼠体内的药代动力学及体外CYP450酶活性的影响研究

消癌平注射液对多西紫杉醇在大鼠体内的药代动力学及体外CYP450酶活性的影响研究

扫码查看
目的 探讨消癌平注射液(XAP)对大鼠体内多西紫杉醇(DOC)药代动力学与体外细胞色素P450(CYP450)酶活性的影响.方法 对 24 只SD雄性大鼠实施体内研究,随机分为A组(DOC对照组)、B组(XAP+DOC组)、C组[(咪达唑仑(MDZ)对照组)]、D组(XAP+MDZ组)共 4 组.借助超高效液相色谱串联质谱法检测给药后 5、10、20、30 min和 1、2、3、4、6、8、12、24 h大鼠血清中DOC/MDZ浓度,计算药代动力学参数.通过重组CYP450 酶 3A4(CYP3A4)的体外反应体系展开研究,制备人肝微粒体,以MDZ为底物探究XAP对CYP450 酶活性的抑制作用,考察XAP对DOC代谢的影响.结果 体内药代动力学结果显示,XAP可使DOC的Cmax 和AUC0→t 分别增加 150%(P<0.01)和60%(P<0.05);t1/2 和MRT分别为(4.24±1.78)h、(3.92±1.14)h,较DOC对照组显著延长;XAP可使MDZ的消除延长,半衰期t1/2 延长至(0.962±0.19)h,MRT延长至(1.008±0.13)h,药时曲线下面积(AUC0→∞)为(1510.078±242.11)ng·h/ml,均显著高于MDZ对照组(P<0.05).以MDZ为底物进行的体外抑制实验表明,XAP(10~100 mg/ml)和C21 总甾体提取物(10~50 μg/ml)能明显抑制人肝微粒体CYP3A4 活性.结论 XAP与DOC联合使用后,DOC的血药浓度升高,DOC的多个药代动力学参数明显改变,XAP对DOC的消除有抑制效能,同时其作用机制可能与CYP3A4 受抑制有关.
The effects of Xiao-Ai-Ping injection on the pharmacokinetics by docetaxel in vivo and CYP450 enzyme activity in vitro of rats
Objective To explore the effects of Xiao-Ai-Ping injection(XAP)on the pharmacokinetics of docetaxel(DOC)in vivo and the activity of human cytochrome P450(CYP450)enzyme in vitro of rats.Methods Twenty-four male SD rats were randomly divided into four groups:DOC control group(Group A),XAP+DOC group(Group B),midazolam(MDZ)control group(Group C)and XAP+MDZ group(Group D)for in vivo research.Ultra high performance liquid chromatography tandem mass spectrometry was used to detect the concentration of DOC/MDZ in rat serum at 5,10,20,30 min and 1,2,3,4,6,8,12,24 h after administration,and the pharmacokinetic parameters was calculated.A recombinant human cytochrome P450 enzyme 3A4(CYP3A4)was used for in vitro study.A study was conducted on the in vitro reaction system of CYP3A4.Human liver microsomes was prepared.The inhibitory effect of XAP on CYP450 activity was investigated using MDZ as the substrate,and the effect of XAP on DOC metabolism was investigated.Results In vivo pharmacokinetic results showed that XAP could increase the Cmax and AUC0 → t of DOC by 150%(P<0.01)and 60%(P<0.05),respectively.The t1/2 and MRT values were(4.24±1.78)h and(3.92±1.14)h,respectively,which were significantly prolonged compared to the DOC control group.XAP could prolong the elimination half-life of MDZ by t1/2 to(0.962±0.19)h,MRT to(1.008±0.13)h,and AUC0→∞ to(1510.078±242.11)ng·h/ml.Both were significantly higher than those in MDZ control group(P<0.05).The in vitro inhibition experiment using MDZ as the substrate showed that XAP(10-100 mg/ml)and C21 total steroid extract(10-50 μg/ml),had a significant inhibitory effect on the activity of human liver microsomal CYP3A4.Conclusion After combined use of XAP and DOC,the blood concentration of DOC increases,and multiple pharmacokinetic parameters of DOC show significant changes.XAP has an inhibitory effect on the elimination of DOC,and this effect may be caused by the inhibition of CYP3A4.

TumorXiao-Ai-Ping injectionDocetaxelCytochrome P450Drug(traditional Chinese medicine)-drug interactionPharmacokineticsCytochrome P450 enzyme 3A4

陈诗绮、张凤、庞涛、焦晓栋、柳珂

展开 >

200070 上海 海军军医大学第二附属医院肿瘤科

肿瘤 消癌平注射液 多西紫杉醇 细胞色素P450 药物(中药)-药物相互作用 药代动力学 细胞色素P450酶3A4

2024

临床肿瘤学杂志
解放军第八一医院

临床肿瘤学杂志

CSTPCD
影响因子:1.583
ISSN:1009-0460
年,卷(期):2024.29(1)
  • 18